Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011).
about
Proteus mirabilis and Urinary Tract Infections.Resistance mechanismsFosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.Catheter associated urinary tract infectionsBacterial uropathogens isolates and antibiograms in children under 5 years of ageClinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study.Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial.Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.Epidemiology of antimicrobial resistance in bloodstream infections.Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014.Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections.Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury/disorder over the past 9 years.Distribution of extended-spectrum β-lactamase types in a Brazilian tertiary hospital.Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
P2860
Q26779002-75279563-23D3-4636-A2A4-0BDBE992C01EQ28069941-1DB6CE32-29AD-4157-83AB-EC7B98E88CBDQ33732529-03956929-6279-42C8-8201-3D1EDE85DFA3Q33968522-B495491F-5803-43A7-A40D-69DB48599A0DQ34557104-233B0D7C-B9C0-4FC9-90E5-CE700D13CF98Q34710133-E5E63E59-9AD7-4C1F-B5F5-50B71AA36462Q35901067-D71AACE7-35AF-45F7-8D14-2C03AF18D1A8Q36204123-D72F7414-623B-42FE-97F2-5918918A766DQ36913239-3B0C0909-853D-420F-A996-091F0AFED0BDQ37023324-23A6F433-B3F0-47FF-AC1F-2219DF162BDAQ37120046-77003304-E0C3-445B-A781-B8154246A488Q38543002-23B92772-7F11-4B91-BCAA-B0D3BBA56939Q40332697-887A28F8-06FD-40D1-BBC1-D4D930F4D2F0Q40919770-483FF74B-1BAE-42FB-9176-917DA90E0D20Q40933499-5F981F08-810C-49E8-A50A-091EA3909278
P2860
Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011).
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Frequency of occurrence and an ...... uropean hospitals (2009-2011).
@ast
Frequency of occurrence and an ...... uropean hospitals (2009-2011).
@en
type
label
Frequency of occurrence and an ...... uropean hospitals (2009-2011).
@ast
Frequency of occurrence and an ...... uropean hospitals (2009-2011).
@en
prefLabel
Frequency of occurrence and an ...... uropean hospitals (2009-2011).
@ast
Frequency of occurrence and an ...... uropean hospitals (2009-2011).
@en
P2860
P1476
Frequency of occurrence and an ...... uropean hospitals (2009-2011).
@en
P2093
Ronald N Jones
P2860
P304
P356
10.1179/1973947813Y.0000000121
P577
2013-12-06T00:00:00Z